REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir
Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta wi...
Gespeichert in:
Veröffentlicht in: | Cancer epidemiology 2021-12, Vol.75, p.102047-102047, Article 102047 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 102047 |
---|---|
container_issue | |
container_start_page | 102047 |
container_title | Cancer epidemiology |
container_volume | 75 |
creator | Jamwal, Rajeshwer Singh Mahajan, Nikita Bhat, Gh. Rasool Bhat, Amrita Shah, Ruchi Verma, Sonali Sharma, Minerva Sharma, Bhawani Qadri, Raies A. Kumar, Rakesh Bhat, Audesh |
description | Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&K) for the potential role of REV3L gene polymorphisms in NSCLC.
A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression.
Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively.
Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers.
Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request.
•Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking. |
doi_str_mv | 10.1016/j.canep.2021.102047 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2582806949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782121001648</els_id><sourcerecordid>2582806949</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqXwBEjIEhs2GXyJnWTBAlXlOlKlqkLsLMc-aT1y7OBLUZ-hL42HKV10wca27O-c8_v_m-Y1wRuCiXi_22jlYd1QTEm9objrnzTHZOj7th_Yz6cPZ0qOmhcp7TAWghD-vDlineB8pOy4ubs4-8G2KFl_5QD5oh2EbA2gGxWt8jkhB8qgHJD1OoJKYFAqScOa7WSdzbf17beKJiEffJsW5RzSUBdX_BWqCjXEWovyNaA1rMWpbINHYUbf1LIUpLxB31W6Xmx82TyblUvw6n4_aS4_nV2efmm355-_nn7ctpoNfW65FhOehOGsJ8SQadbAuqn-ZzQj4aYDMRsGmBszKwqc8cko3Rs2YmLooNhJ8-7Qdo3hV4GU5WLTXnJ1M5QkKR_ogMXYjRV9-wjdhRJ9FSepwJj2gglWKXagdAwpRZjlGu2i4q0kWO6jkjv5Nyq5j0oeoqpVb-57l2kB81DzL5sKfDgAUL24sRBl0haqn8ZG0FmaYP874A8gUae6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2600276363</pqid></control><display><type>article</type><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</creator><creatorcontrib>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</creatorcontrib><description>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&K) for the potential role of REV3L gene polymorphisms in NSCLC.
A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression.
Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively.
Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers.
Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request.
•Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2021.102047</identifier><identifier>PMID: 34655923</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Body mass index ; Cancer ; Carcinoma, Non-Small-Cell Lung - epidemiology ; Carcinoma, Non-Small-Cell Lung - genetics ; Case-Control Studies ; Cell cycle ; Chemical synthesis ; DNA damage ; DNA polymerase zeta ; DNA repair gene ; DNA-Binding Proteins - genetics ; DNA-Directed DNA Polymerase - genetics ; Epidemiology ; Gene polymorphism ; Genes ; Genetic Predisposition to Disease ; Genomes ; Genotyping ; Haplotypes ; Humans ; Lung cancer ; Lung Neoplasms - epidemiology ; Lung Neoplasms - genetics ; Males ; Materials information ; Mutation ; Non-small cell lung cancer (NSCLC) ; Non-small cell lung carcinoma ; Nucleotides ; Polymorphism, Single Nucleotide ; Population ; Population studies ; Regression analysis ; REV3L (Protein reversion less 3-like) ; Reversion ; Small cell lung carcinoma ; Squamous cell carcinoma ; World population</subject><ispartof>Cancer epidemiology, 2021-12, Vol.75, p.102047-102047, Article 102047</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</citedby><cites>FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</cites><orcidid>0000-0002-2892-3910</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2600276363?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34655923$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jamwal, Rajeshwer Singh</creatorcontrib><creatorcontrib>Mahajan, Nikita</creatorcontrib><creatorcontrib>Bhat, Gh. Rasool</creatorcontrib><creatorcontrib>Bhat, Amrita</creatorcontrib><creatorcontrib>Shah, Ruchi</creatorcontrib><creatorcontrib>Verma, Sonali</creatorcontrib><creatorcontrib>Sharma, Minerva</creatorcontrib><creatorcontrib>Sharma, Bhawani</creatorcontrib><creatorcontrib>Qadri, Raies A.</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bhat, Audesh</creatorcontrib><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&K) for the potential role of REV3L gene polymorphisms in NSCLC.
A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression.
Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively.
Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers.
Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request.
•Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</description><subject>Body mass index</subject><subject>Cancer</subject><subject>Carcinoma, Non-Small-Cell Lung - epidemiology</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Case-Control Studies</subject><subject>Cell cycle</subject><subject>Chemical synthesis</subject><subject>DNA damage</subject><subject>DNA polymerase zeta</subject><subject>DNA repair gene</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Directed DNA Polymerase - genetics</subject><subject>Epidemiology</subject><subject>Gene polymorphism</subject><subject>Genes</subject><subject>Genetic Predisposition to Disease</subject><subject>Genomes</subject><subject>Genotyping</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - genetics</subject><subject>Males</subject><subject>Materials information</subject><subject>Mutation</subject><subject>Non-small cell lung cancer (NSCLC)</subject><subject>Non-small cell lung carcinoma</subject><subject>Nucleotides</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Population</subject><subject>Population studies</subject><subject>Regression analysis</subject><subject>REV3L (Protein reversion less 3-like)</subject><subject>Reversion</subject><subject>Small cell lung carcinoma</subject><subject>Squamous cell carcinoma</subject><subject>World population</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kctu1DAUhiMEoqXwBEjIEhs2GXyJnWTBAlXlOlKlqkLsLMc-aT1y7OBLUZ-hL42HKV10wca27O-c8_v_m-Y1wRuCiXi_22jlYd1QTEm9objrnzTHZOj7th_Yz6cPZ0qOmhcp7TAWghD-vDlineB8pOy4ubs4-8G2KFl_5QD5oh2EbA2gGxWt8jkhB8qgHJD1OoJKYFAqScOa7WSdzbf17beKJiEffJsW5RzSUBdX_BWqCjXEWovyNaA1rMWpbINHYUbf1LIUpLxB31W6Xmx82TyblUvw6n4_aS4_nV2efmm355-_nn7ctpoNfW65FhOehOGsJ8SQadbAuqn-ZzQj4aYDMRsGmBszKwqc8cko3Rs2YmLooNhJ8-7Qdo3hV4GU5WLTXnJ1M5QkKR_ogMXYjRV9-wjdhRJ9FSepwJj2gglWKXagdAwpRZjlGu2i4q0kWO6jkjv5Nyq5j0oeoqpVb-57l2kB81DzL5sKfDgAUL24sRBl0haqn8ZG0FmaYP874A8gUae6</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Jamwal, Rajeshwer Singh</creator><creator>Mahajan, Nikita</creator><creator>Bhat, Gh. Rasool</creator><creator>Bhat, Amrita</creator><creator>Shah, Ruchi</creator><creator>Verma, Sonali</creator><creator>Sharma, Minerva</creator><creator>Sharma, Bhawani</creator><creator>Qadri, Raies A.</creator><creator>Kumar, Rakesh</creator><creator>Bhat, Audesh</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2892-3910</orcidid></search><sort><creationdate>202112</creationdate><title>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</title><author>Jamwal, Rajeshwer Singh ; Mahajan, Nikita ; Bhat, Gh. Rasool ; Bhat, Amrita ; Shah, Ruchi ; Verma, Sonali ; Sharma, Minerva ; Sharma, Bhawani ; Qadri, Raies A. ; Kumar, Rakesh ; Bhat, Audesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-5c6b0b6d53711d1bfce34b5599d915d4e6fd3e05ddfa2e535bdac7d3901d28a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Body mass index</topic><topic>Cancer</topic><topic>Carcinoma, Non-Small-Cell Lung - epidemiology</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Case-Control Studies</topic><topic>Cell cycle</topic><topic>Chemical synthesis</topic><topic>DNA damage</topic><topic>DNA polymerase zeta</topic><topic>DNA repair gene</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Directed DNA Polymerase - genetics</topic><topic>Epidemiology</topic><topic>Gene polymorphism</topic><topic>Genes</topic><topic>Genetic Predisposition to Disease</topic><topic>Genomes</topic><topic>Genotyping</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - genetics</topic><topic>Males</topic><topic>Materials information</topic><topic>Mutation</topic><topic>Non-small cell lung cancer (NSCLC)</topic><topic>Non-small cell lung carcinoma</topic><topic>Nucleotides</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Population</topic><topic>Population studies</topic><topic>Regression analysis</topic><topic>REV3L (Protein reversion less 3-like)</topic><topic>Reversion</topic><topic>Small cell lung carcinoma</topic><topic>Squamous cell carcinoma</topic><topic>World population</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jamwal, Rajeshwer Singh</creatorcontrib><creatorcontrib>Mahajan, Nikita</creatorcontrib><creatorcontrib>Bhat, Gh. Rasool</creatorcontrib><creatorcontrib>Bhat, Amrita</creatorcontrib><creatorcontrib>Shah, Ruchi</creatorcontrib><creatorcontrib>Verma, Sonali</creatorcontrib><creatorcontrib>Sharma, Minerva</creatorcontrib><creatorcontrib>Sharma, Bhawani</creatorcontrib><creatorcontrib>Qadri, Raies A.</creatorcontrib><creatorcontrib>Kumar, Rakesh</creatorcontrib><creatorcontrib>Bhat, Audesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jamwal, Rajeshwer Singh</au><au>Mahajan, Nikita</au><au>Bhat, Gh. Rasool</au><au>Bhat, Amrita</au><au>Shah, Ruchi</au><au>Verma, Sonali</au><au>Sharma, Minerva</au><au>Sharma, Bhawani</au><au>Qadri, Raies A.</au><au>Kumar, Rakesh</au><au>Bhat, Audesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2021-12</date><risdate>2021</risdate><volume>75</volume><spage>102047</spage><epage>102047</epage><pages>102047-102047</pages><artnum>102047</artnum><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>Non-small cell lung cancer (NSCLC) is the most common lung cancer, accounting for 80–85% of all lung cancer cases. Various genetic studies have associated REV3L (Protein reversion less 3-like) gene mutations, which encodes the catalytic subunit of error prone translesion synthesis polymerase zeta with cancer, including lung cancer; however, no such data is available from any North Indian population. In this study we attempted to screen the North Indian population of Jammu and Kashmir (J&K) for the potential role of REV3L gene polymorphisms in NSCLC.
A total of four REV3L single nucleotide variants were selected for genotyping based on the available literature. The genotyping was carried out by using the TaqMan allele discrimination assay in 500 subjects (200 NSCLC patients and 300 age and sex matched healthy controls). The association of variants with NSCLC was evaluated by logistic regression.
Out of the four REV3L variants genotyped; rs1002481, rs462779, and rs465646 were found significantly associated with NSCLC risk under the recessive model, with an Odds Ratio (OR) of 3.52(2.14–5.8 at 95% CI, p-value = 0.00000062), 3.7 (1.8–7.6 at 95% CI, p-value = 0.00031), and 2.2 (1.47–3.37 at 95% CI, p-value = 0.0003), respectively.
Our data supports a strong association between variants rs1002481, rs462779, rs465646 and NSCLC, indicating a potential role of these REV3L variants in increasing the risk for the development of NSCLC in the studied population. Although a first report from any Indian population, these variants have been previously reported to be associated with lung and colorectal cancers in different world populations. Our data along with the existing data supports the notation that these variants can be used as potential genetic predisposition markers.
Data generated and analysed during study is not available publicly but can be made available from the corresponding author upon reasonable request.
•Translesion DNA polymerases are emerging as an important player in oncogenesis.•Recent studies have highlighted the role of these genes as a cause for increased susceptibility towards different cancers.•Our study is a first report from any North Indian population showing the role of TLS gene polymorphisms in cancer.•Of the four SNVs genotype, we found three SNVs significantly associated with NSCLC.•The association of these SNVs was significantly correlated with the habit of smoking.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>34655923</pmid><doi>10.1016/j.canep.2021.102047</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-2892-3910</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1877-7821 |
ispartof | Cancer epidemiology, 2021-12, Vol.75, p.102047-102047, Article 102047 |
issn | 1877-7821 1877-783X |
language | eng |
recordid | cdi_proquest_miscellaneous_2582806949 |
source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Body mass index Cancer Carcinoma, Non-Small-Cell Lung - epidemiology Carcinoma, Non-Small-Cell Lung - genetics Case-Control Studies Cell cycle Chemical synthesis DNA damage DNA polymerase zeta DNA repair gene DNA-Binding Proteins - genetics DNA-Directed DNA Polymerase - genetics Epidemiology Gene polymorphism Genes Genetic Predisposition to Disease Genomes Genotyping Haplotypes Humans Lung cancer Lung Neoplasms - epidemiology Lung Neoplasms - genetics Males Materials information Mutation Non-small cell lung cancer (NSCLC) Non-small cell lung carcinoma Nucleotides Polymorphism, Single Nucleotide Population Population studies Regression analysis REV3L (Protein reversion less 3-like) Reversion Small cell lung carcinoma Squamous cell carcinoma World population |
title | REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T21%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=REV3L%20single%20nucleotide%20variants%20lead%20to%20increased%20susceptibility%20towards%20non-small%20cell%20lung%20cancer%20in%20the%20population%20of%20Jammu%20and%20Kashmir&rft.jtitle=Cancer%20epidemiology&rft.au=Jamwal,%20Rajeshwer%20Singh&rft.date=2021-12&rft.volume=75&rft.spage=102047&rft.epage=102047&rft.pages=102047-102047&rft.artnum=102047&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2021.102047&rft_dat=%3Cproquest_cross%3E2582806949%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2600276363&rft_id=info:pmid/34655923&rft_els_id=S1877782121001648&rfr_iscdi=true |